Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-08-27

FDA Approved: STRIBILD — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved STRIBILD (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate) as a single-tablet regimen for the treatment of HIV-1 infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)

Snippet

ORIG AP for STRIBILD (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE)